Oral antiplatelet therapy for acute ischaemic stroke (Q24197866)

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

16 May 2020

Mei-Chiun Tseng

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

16 May 2020

Emanuela Cecconi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

16 May 2020

Peter A G Sandercock

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

Cochrane Database of Systematic Reviews

16 May 2020

publication date

25 March 2014

0 references

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

16 May 2020

page(s)

CD000029

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

16 May 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

Effects of ticlopidine on the neurologic outcome and the hemorheologic pattern in the postacute phase of ischemic stroke: a pilot study.

16 May 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Aspirin in the prevention of progressing stroke: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of a randomized phase 2 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Dose-finding, safety, and tolerability study of an oral platelet glycoprotein IIb/IIIa inhibitor, lotrafiban, in patients with coronary or cerebral atherosclerotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Design of the Blockade of the Glycoprotein IIb/IIIa Receptor to Avoid Vascular Occlusion (BRAVO) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

The Japanese aggrenox (extended-release dipyridamole plus aspirin) stroke prevention versus aspirin programme (JASAP) study: a randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Ischemic brain tissue salvaged from infarction by the GP IIb/IIIa platelet antagonist tirofiban

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Safety of Tirofiban in acute Ischemic Stroke: the SaTIS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

The effect of combined thrombolysis with rtPA and tirofiban on ischemic brain lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Cerebral Microembolism Is Blocked by Tirofiban, a Selective Nonpeptide Platelet Glycoprotein IIb/IIIa Receptor Antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Heart Disease and Stroke Statistics--2013 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Pentoxifylline, propentofylline and pentifylline for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Indications for early aspirin use in acute ischemic stroke : A combined analysis of 40 000 randomized patients from the chinese acute stroke trial and the international stroke trial. On behalf of the CAST and IST collaborative groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Glycoprotein IIb-IIIa inhibitors for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Aspirin to prevent heart attack and stroke: what's the right dose?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Complications after acute stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Early treatment with aspirin plus extended-release dipyridamole for transient ischaemic attack or ischaemic stroke within 24 h of symptom onset (EARLY trial): a randomised, open-label, blinded-endpoint trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Effect of clopidogrel on the rate and functional severity of stroke among high vascular risk patients: a prespecified substudy of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management and Avoidance (CHARISMA) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Multiple versus one or more antiplatelet agents for preventing early recurrence after ischaemic stroke or transient ischaemic attack

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Antithrombotic therapy in patients with any form of intracranial haemorrhage: a systematic review of the available controlled studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Mortality by cause for eight regions of the world: Global Burden of Disease Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Tissue plasminogen activator for acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Randomisation to protect against selection bias in healthcare trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Aspirin as an antiplatelet drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Platelet-active drugs: the relationships among dose, effectiveness, and side effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Preventing stroke: saving lives around the world.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Evidence for episodic platelet activation in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Platelet activation and lipid peroxidation in patients with acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Thrombolysis for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Ozagrel for acute ischemic stroke: a meta-analysis of data from randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Antiplatelet therapy for acute ischaemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000029.PUB3

Randomised controlled trial of streptokinase, aspirin, and combination of both in treatment of acute ischaemic stroke. Multicentre Acute Stroke Trial--Italy (MAST-I) Group

21 January 2018

1 reference

12 December 2020

Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II)

1 reference

12 December 2020

Organised inpatient (stroke unit) care for stroke

1 reference

12 December 2020

Ticlopidine-pentoxifylline combination in the treatment of atherosclerosis and the prevention of cerebrovascular accidents

1 reference

12 December 2020

[The effects of ligustrazine, aspirin and beta-histine on platelet aggregation in patients with acute ischemic stroke]

1 reference

12 December 2020

Collaborative overview of randomised trials of antiplatelet therapy--III: Reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration

1 reference

12 December 2020

Aspirin: dose and indications in modern stroke prevention

1 reference

12 December 2020

Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study

1 reference

12 December 2020

Study design of the International Stroke Trial (IST), baseline data, and outcome in 984 randomised patients in the pilot study

1 reference

12 December 2020

Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial

1 reference

12 December 2020

Safety and tolerability of 600 mg clopidogrel bolus in patients with acute ischemic stroke: preliminary experience.

1 reference

12 December 2020

Guidelines for Management of Ischaemic Stroke and Transient Ischaemic Attack 2008

1 reference

12 December 2020

Statistical analysis plan for the 'Triple Antiplatelets for Reducing Dependency after Ischaemic Stroke' (TARDIS) trial.

1 reference

12 December 2020

Effect of therapy on platelet activating factor-induced aggregation in acute stroke

1 reference

12 December 2020

Interobserver agreement for the assessment of handicap in stroke patients

1 reference

12 December 2020

CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. CAST (Chinese Acute Stroke Trial) Collaborative Group

1 reference

12 December 2020

The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. International Stroke Trial Collaborative Group

1 reference

12 December 2020

Prostacyclin and analogues for acute ischaemic stroke

1 reference

12 December 2020

Abciximab in acute ischemic stroke. A randomized, double-blind, placebo-controlled, dose-escalation study

1 reference

12 December 2020

Hemorrheological study on the effect of acupuncture in treating cerebral infarction

1 reference

12 December 2020

Randiomized trial of a new platelet anti-aggregant agent: ticlopidine

1 reference

12 December 2020

Effect of clopidogrel plus ASA vs. ASA early after TIA and ischaemic stroke: a substudy of the CHARISMA trial

1 reference

12 December 2020

1 reference

12 December 2020

Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction

1 reference

12 December 2020

Piracetam for acute ischaemic stroke

1 reference

12 December 2020

Fatal hemorrhagic transformation of acute cerebral infarction after the use of abciximab

1 reference

12 December 2020

10.1002/14651858.CD000029.PUB3

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

4830601

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

OpenCitations bibliographic resource ID

16 May 2020

4830601

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6669270&resulttype=core&format=json

16 May 2020

1 reference